Bliss Gvs Hemorrhoidal Suppository
NDC Package 72701-110-12
Package Information
Bliss Gvs Hemorrhoidal (hard fat, phenylephrine hcl) suppositories is usestemporarily shrinks hemorrhoidal tissuetemporarily relieves the itching, burning and discomfort associated with hemorrhoids. This formulation utilizes a suppository delivery system. Marketed by Bliss Gvs Pharma Limited, this product is identified by NDC 72701-110 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 2715398 - phenylephrine hydrochloride 0.25 % Rectal Suppository
- RxCUI: 2715398 - phenylephrine hydrochloride 0.0025 MG/MG Rectal Suppository
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72701 - Bliss Gvs Pharma Limited
- 72701-110 - Bliss Gvs Hemorrhoidal
- 72701-110-12 - 2 BLISTER PACK in 1 CARTON / 6 SUPPOSITORY in 1 BLISTER PACK
- 72701-110 - Bliss Gvs Hemorrhoidal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72701-110). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72701-110-12 identifies a specific commercial package of 2 blister pack in 1 carton / 6 suppository in 1 blister pack of Bliss Gvs Hemorrhoidal, a human over the counter drug labeled by Bliss Gvs Pharma Limited. This suppository is formulated for rectal use and contains hard fat; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bliss Gvs Pharma Limited on May 13, 2019. The current certification is valid through December 31, 2026.
How is this Bliss Gvs Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72701011012. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.